IPO Price History
Closed
Nephrocare Health Services Limited logo

Nephrocare Health Services Limited IPO

Mainboard IPOListedNEPHROPLUSNSE
Current Market Price (CMP)
₹596.45(+29.66%)
Current Price (CMP)
₹596.45(+29.66%)

Live Market Quote

Listing Price & Gain
₹471.25(+2.45%)

Day 1 Exchange Open

IPO Issue Price
₹460

Band: ₹438 - ₹460

Total Subscription
13.96x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
10 Dec 2025
IPO Bidding Closes
12 Dec 2025
Allotment & Refunds
Completed
Exchange Listing Day
17 Dec 2025

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 13.96x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)27.47x
Non-Institutional Investors (NII / HNI)24.27x
Retail Individual Investors (RII)2.31x
Employees Reservation2.67x
Total Subscription13.96x
Updated as on 12-Dec-2025 19:00:00

Listing Day & Return Performance

Listing Day Gain+2.45%
₹460 (Issue) → ₹471.25 (List)
Per share profit: +₹11.25
Holding Return (Till Date)+29.66%
₹460 (Issue) → ₹596.45 (CMP)
Net gain per share: +₹136.45
Post-Listing Performance (Listing Day → Today):+26.57%

About Nephrocare Health Services Limited IPO

Nephrocare Health Services Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 10 Dec 2025 and concluded on 12 Dec 2025, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹438 - ₹460.

During the bidding window, Nephrocare Health Services Limited witnessed heavy demand with an overall subscription of 13.96 times. Institutional investors (QIB) subscribed 27.47x, non-institutional high-net-worth investors (NII) subscribed 24.27x, and retail individual investors (RII) bid 2.31x their reserved quota, alongside employee participation of 2.67x.

The equity shares of Nephrocare Health Services Limited officially debuted on the stock exchanges on 17 Dec 2025 at an opening listing price of ₹471.25, delivering a listing day return of +2.45% (premium) over the final issue price. As per the latest market data, the stock trades at ₹596.45, representing an overall gain of +29.66% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Nephrocare Health Services Limited IPO?
The issue price of Nephrocare Health Services Limited IPO was fixed at ₹460 per equity share. The indicative bidding price band was ₹438 - ₹460.
What were the open, close, and listing dates for Nephrocare Health Services Limited IPO?
Nephrocare Health Services Limited IPO opened on 10 Dec 2025, closed on 12 Dec 2025, listed on 17 Dec 2025.
How much was Nephrocare Health Services Limited IPO subscribed?
The IPO received an overall subscription of 13.96 times. Category-wise, QIBs subscribed 27.47x, NIIs subscribed 24.27x, and Retail investors subscribed 2.31x.
What was the listing price and listing gain of Nephrocare Health Services Limited IPO?
Nephrocare Health Services Limited IPO listed on the stock exchange at ₹471.25, delivering a listing gain of 2.45% compared to the IPO issue price of ₹460.
Is Nephrocare Health Services Limited IPO a Mainboard or SME IPO?
Nephrocare Health Services Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Nephrocare Health Services Limited IPO since its IPO?
At the latest market quote of ₹596.45, Nephrocare Health Services Limited IPO has generated an all-time return of +29.66% since its initial public offering.

Related Mainboard IPOs (2025)

GKSL
Gujarat Kidney and Super Speciality Limited
₹114-8.30%
KSHINTL
KSH International Limited
₹384-7.55%
ICICIAMC
ICICI Prudential Asset Management Company Limited
₹2,165-99.91%
PARKHOSPS
Park Medi World Limited
₹162-8.67%